CD56brightCD16+ NK cells expressing KIR2DL1 were significantly increased in severe CFS/ME patients after 6 months (p = 0.011) (Fig. 4b). The gene discussed is KIR2DL1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.